Related Experiment Video

Updated: May 19, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

DNA methylation and microRNA dysregulation in cancer

Hiromu Suzuki1, Reo Maruyama, Eiichiro Yamamoto

  • 1Department of Molecular Biology, Sapporo Medical University, S1 W17, Chuo-Ku, Sapporo 060-8556, Japan. hsuzuki@sapmed.ac.jp

Molecular Oncology
|August 21, 2012
PubMed

Insights

DNA methylation significantly impacts cancer by altering gene and microRNA (miRNA) expression. Aberrant DNA methylation in miRNA genes is a key factor in cancer development and progression, offering potential diagnostic and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • DNA methylation is crucial for gene silencing and cellular processes, with alterations observed in malignancies.
  • MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression post-transcriptionally and are frequently dysregulated in cancer.

Purpose of the Study:

  • To investigate the role of DNA methylation in the dysregulation of microRNAs (miRNAs) in cancer.
  • To identify epigenetically regulated miRNAs and their implications in cancer development and progression.

Main Methods:

  • Analysis of miRNA expression profiles and epigenome in cancer cells using advanced technologies.
  • Identification of specific DNA methylation patterns, including CpG island hypermethylation and hypomethylation, associated with miRNA gene silencing.

Main Results:

  • DNA methylation, particularly CpG island hypermethylation, silences miRNA genes involved in cancer-related pathways.
  • Aberrant DNA methylation in CpG island shores and DNA hypomethylation also contribute to miRNA dysregulation in cancer.
  • Epigenetically regulated miRNAs are identified as potential biomarkers for cancer detection and outcome prediction.

Conclusions:

  • Aberrant DNA methylation of miRNA genes is a significant mechanism driving cancer progression.
  • Targeting miRNA re-expression or using miRNA mimics presents a promising therapeutic strategy for cancer treatment.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...